B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: Implications for disease pathogenesis

Journal of Immunology

Volumn 181, Issue 8, 2008, Pages 5768-5774

  Douglas, Raymond S ^a,b,c   Naik, Vibharavi ^b   Hwang, Catherine J ^b   Afifiyan, Nikoo F ^a   Gianoukakis, Andrew G ^a,c   Sand, Daniel ^a   Kamat, Shweta ^a   Smith, Terry J ^a,b,c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b JULES STEIN EYE INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHEMOATTRACTANT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 16; RANTES; SOMATOMEDIN C RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; IMMUNOLOGICAL ADJUVANT; OLIGODEOXYRIBONUCLEOTIDE; THYROTROPIN RECEPTOR;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BLOOD; BONE MARROW; CELL COUNT; CELL EXPANSION; CELL POPULATION; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROL GROUP; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROBLAST; FLOW CYTOMETRY; GRAVES DISEASE; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; MEMORY T LYMPHOCYTE; ORBIT; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; THYROID GLAND; TIBIALIS ANTERIOR MUSCLE; BIOSYNTHESIS; CLINICAL TRIAL; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; AUTOANTIBODIES; B-LYMPHOCYTES; BONE MARROW; CONNECTIVE TISSUE; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; GRAVES DISEASE; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; OLIGODEOXYRIBONUCLEOTIDES; ORBIT; RECEPTOR, IGF TYPE 1; RECEPTORS, THYROTROPIN; T-LYMPHOCYTES;

EID: 54049100737     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.8.5768     Document Type: Article

References (59)

1. Dorner, T., and P. E. Lipsky. 2006. Signalling pathways in B cells: implications for autoimmunity. Curr. Top Microbiol. Immunol. 305: 213-240. (Pubitemid 47400260)
2. Martinez-Gamboa, L., H. P. Brezinschek, G. R. Burmester, and T. Dorner. 2006. Immunopathologic role of B lymphocytes in rheumatoid arthritis: rationale of B cell-directed therapy. Autoimmun. Rev. 5: 437-442. (Pubitemid 44233402)
3. Prabhakar, B. S., R. S. Bahn, and T. J. Smith. 2003. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr. Rev. 24: 802-835. (Pubitemid 38067700)
4. Tandon, N., R. A. Metcalfe, D. Barnett, and A. P. Weetman. 1994. Expression of the costimulatory molecule B7/BB1 in autoimmune thyroid disease. Q. J. Med. 87: 231-236. (Pubitemid 24113250)
5. Sato, S., M. Fujimoto, M. Hasegawa, K. Takehara, and T. F. Tedder. 2004. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis. Mol. Immunol. 41: 1123-1133. (Pubitemid 39346261)
6. Bour-Jordan, H., B. L. Salomon, H. L. Thompson, R. Santos, A. K. Abbas, and J. A. Bluestone. 2007. Constitutive expression of B7-1 on B cells uncovers autoimmunity toward the B cell compartment in the nonobese diabetic mouse. J. Immunol. 179: 1004-1012.
7. El Fassi, D., C. H. Nielsen, H. C. Hasselbalch, and L. Hegedus. 2006. The rationale for B lymphocyte depletion in Graves' disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option. Eur. J. Endocrinol. 154: 623-632. (Pubitemid 43810846)
8. Aggarwal, B. B., S. Shishodia, Y. Takada, D. Jackson-Bernitsas, K. S. Ahn, G. Sethi, and H. Ichikawa. 2006. TNF blockade: an inflammatory issue. Ernst Schering Res. Found. Workshop 56: 161-186.
9. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19: 683-765.
10. Salmaso, C., D. Olive, G. Pesce, and M. Bagnasco. 2002. Costimulatory molecules and autoimmune thyroid diseases. Autoimmunity 35: 159-167. (Pubitemid 34678736)
11. Yanaba, K., Y. Hamaguchi, G. M. Venturi, D. A. Steeber, E. W. St. Clair, and T. F. Tedder. 2007. B cell depletion delays collagen-induced arthritis in mice: arthritis induction requires synergy between humoral and cell-mediated immunity. J. Immunol. 179: 1369-1380.
12. Nielsen, C. H., D. El Fassi, H. C. Hasselbalch, K. Bendtzen, and L. Hegedus. 2007. B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family. Expert Opin. Biol. Ther. 7: 1061-1078.
13. Chen, C. R., P. Pichurin, Y. Nagayama, F. Latrofa, B. Rapoport, and S. M. McLachlan. 2003. The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim. J. Clin. Invest. 111: 1897-1904.
14. Akamizu, T. 2003. Monoclonal antibodies to thyroid specific autoantigens. Autoimmunity 36: 361-366. (Pubitemid 37160524)
15. Pritchard, J., R. Han, N. Horst, W. W. Cruikshank, and T. J. Smith. 2003. Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway. J. Immunol. 170: 6348-6354. (Pubitemid 36682621)
16. Pritchard, J., N. Horst, W. Cruikshank, and T. J. Smith. 2002. Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts. J. Immunol. 168: 942-950. (Pubitemid 34049599)
17. Bateman, J. M., and H. McNeill. 2006. Insulin/IGF signalling in neurogenesis. Cell Mol. Life Sci. 63: 1701-1705.
18. Binz, K., P. Joller, P. Froesch, H. Binz, J. Zapf, and E. R. Froesch. 1990. Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 87: 3690-3694. (Pubitemid 20182524)
19. Zumkeller, W. 2002. The insulin-like growth factor system in hematopoietic cells. Leuk. Lymphoma 43: 487-491. (Pubitemid 34232914)
20. Reiss, K., P. Porcu, C. Sell, Z. Pietrzkowski, and R. Baserga. 1992. The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells. Oncogene 7: 2243-2248.
21. Roldan, A., E. Charreau, R. Schillaci, E. M. Eugui, and A. C. Allison. 1989. Insulin-like growth factor-1 increases the mitogenic response of human peripheral blood lymphocytes to phytohemagglutinin. Immunol. Lett. 20: 5-8. (Pubitemid 19031187)
22. Kurmasheva, R. T., and P. J. Houghton. 2006. IGF-I mediated survival pathways in normal and malignant cells. Biochim. Biophys. Acta 1766: 1-22.
23. Ahlen, J., J. Wejde, O. Brosjo, A. von Rosen, W. H. Weng, L. Girnita, O. Larsson, and C. Larsson. 2005. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma. Clin. Cancer Res. 11: 206-216. (Pubitemid 40075797)
24. Zadik, Z., Z. Estrov, Y. Karov, T. Hahn, and Y. Barak. 1993. The effect of growth hormone and IGF-I on clonogenic growth of hematopoietic cells in leukemic patients during active disease and during remission: a preliminary report. J. Pediatr. Endocrinol. 6: 79-83. (Pubitemid 23192349)
25. Kooijman, R., M. Willems, C. J. De Haas, G. T. Rijkers, A. L. Schuurmans, S. C. Van Buul-Offers, C. J. Heijnen, and B. J. Zegers. 1992. Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells. Endocrinology 131: 2244-2250.
26. Kooijman, R. K., L. E. Scholtens, G. T. Rijkers, and B. J. Zegers. 1995. Differential expression of type I insulin-like growth factor receptors in different stages of human T cells. Eur. J. Immunol. 25: 931-935.
27. Clark, R., J. Strasser, S. McCabe, K. Robbins, and P. Jardieu. 1993. Insulin-like growth factor-1 stimulation of lymphopoiesis. J. Clin. Invest. 92: 540-548. (Pubitemid 23262369)
28. Jardieu, P., R. Clark, D. Mortensen, and K. Dorshkind. 1994. In vivo administration of insulin-like growth factor-I stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation. J. Immunol. 152: 4320-4327. (Pubitemid 24134389)
29. Alpdogan, O., S. J. Muriglan, B. J. Kappel, E. Doubrovina, C. Schmaltz, R. Schiro, J. M. Eng, A. S. Greenberg, L. M. Willis, J. A. Rotolo, R. J. O'Reilly, and M. R. van den Brink. 2003. Insulin-like growth factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantation. Transplantation 75: 1977-1983. (Pubitemid 36793278)
30. Hettmer, S., L. Dannecker, J. Foell, M. W. Elmlinger, and G. E. Dannecker. 2005. Effects of insulin-like growth factors and insulin-like growth factor binding protein-2 on the in vitro proliferation of peripheral blood mononuclear cells. Hum. Immunol. 66: 95-103. (Pubitemid 40208196)
31. Liu, E., H. K. Law, and Y. L. Lau. 2003. Insulin-like growth factor I promotes maturation and inhibits apoptosis of immature cord blood monocyte-derived dendritic cells through MEK and PI 3-kinase pathways. Pediatr. Res. 54: 919-925. (Pubitemid 37456559)
32. Navarro, M., and R. Baserga. 2001. Limited redundancy of survival signals from the type 1 insulin-like growth factor receptor. Endocrinology 142: 1073-1081. (Pubitemid 32202816)
33. Landreth, K. S., R. Narayanan, and K. Dorshkind. 1992. Insulin-like growth factor-I regulates pro-B cell differentiation. Blood 80: 1207-1212.
34. Kim, J. H., H. H. Park, and C. E. Lee. 2003. IGF-1 potentiation of IL-4-induced CD23/FcεRII expression in human B cells. Mol. Cells 15: 307-312.
35. Douglas, R. S., A. G. Gianoukakis, S. Kamat, and T. J. Smith. 2007. Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis. J. Immunol. 178: 3281-3287.
36. Coligan, J., A. Kruisbeek, D. Marguiles, E. Shevach, and W. Strober, eds. 2006. Current Protocols in Immunology. John Wiley and Sons, New York.
37. Ryan, E. P., S. J. Pollock, T. I. Murant, S. H. Bernstein, R. E. Felgar, and R. P. Phipps. 2005. Activated human B lymphocytes express cyclooxygenase-2 and cyclooxygenase inhibitors attenuate antibody production. J. Immunol. 174: 2619-2626.
38. Fan, J. L., R. K. Desai, J. S. Dallas, N. M. Wagle, G. S. Seetharamaiah, and B. S. Prabhakar. 1994. High frequency of B cells capable of producing antithyrotropin receptor antibodies in patients with Graves' disease. Clin. Immunol. Immunopathol. 71: 69-74. (Pubitemid 24126601)
39. Gibson, L. F., D. Piktel, and K. S. Landreth. 1993. Insulin-like growth factor-1 potentiates expansion of interleukin-7-dependent pro-B cells. Blood 82: 3005-3011.
40. Kimata, H., and M. Fujimoto. 1994. Growth hormone and insulin-like growth factor I induce immunoglobulin (Ig)E and IgG4 production by human B cells. J. Exp. Med. 180: 727-732. (Pubitemid 24224153)
41. Kimata, H., and A. Yoshida. 1994. Differential effect of growth hormone and insulin-like growth factor-I, insulin-like growth factor-II, and insulin on Ig production and growth in human plasma cells. Blood 83: 1569-1574. (Pubitemid 24081571)
42. Kimata, H., and A. Yoshida. 1994. Effect of growth hormone and insulin-like growth factor-I on immunoglobulin production by and growth of human B cells. J. Clin. Endocrinol. Metab. 78: 635-641. (Pubitemid 24083304)
43. De Meyts, P., J. Palsgaard, W. Sajid, A. M. Theede, and H. Aladdin. 2004. Structural biology of insulin and IGF-1 receptors. Novartis Found. Symp. 262: 160-171; discussion 171-176, 265-268.
44. Traggiai, E., S. Becker, K. Subbarao, L. Kolesnikova, Y. Uematsu, M. R. Gismondo, B. R. Murphy, R. Rappuoli, and A. Lanzavecchia. 2004. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. 10: 871-875. (Pubitemid 39070862)
45. Paul, W., ed. 2003. Fundamental Immunology, 5th Ed. Lippincott Williams & Wilkins, Philadelphia, pp. 159-194.
46. Taguchi, T., H. Takenouchi, J. Matsui, W. R. Tang, M. Itagaki, Y. Shiozawa, K. Suzuki, S. Sakaguchi, Y. U. Ktagiri, T. Takahashi, et al. 2006. Involvement of insulin-like growth factor-I and insulin-like growth factor binding proteins in pro-B-cell development. Exp. Hematol. 34: 508-518.
47. Robbins, K., S. McCabe, T. Scheiner, J. Strasser, R. Clark, and P. Jardieu. 1994. Immunological effects of insulin-like growth factor-I: enhancement of immunoglobulin synthesis. Clin. Exp. Immunol. 95: 337-342. (Pubitemid 24207150)
48. Hinton, P. S., C. A. Peterson, E. M. Dahly, and D. M. Ney. 1998. IGF-I alters lymphocyte survival and regeneration in thymus and spleen after dexamethasone treatment. Am. J. Physiol. 274: R912-R920. (Pubitemid 28217740)
49. Stuart, C. A., R. T. Meehan, L. S. Neale, N. M. Cintron, and R. W. Furlanetto. 1991. Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes. J Clin. Endocrinol. Metab. 72: 1117-1122.
50. Baudler, S., J. Baumgartl, B. Hampel, T. Buch, A. Waisman, C. M. Snapper, W. Krone, and J. C. Bruning. 2005. Insulin-like growth factor-1 controls type 2 T cell-independent B cell response. J. Immunol. 174: 5516-5525. (Pubitemid 40593192)
51. Keegan, A. D., K. Nelms, M. White, L. M. Wang, J. H. Pierce, and W. E. Paul. 1994. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 76: 811-820.
52. Keegan, A. D., K. Nelms, L. M. Wang, J. H. Pierce, and W. E. Paul. 1994. Interleukin 4 receptor: signaling mechanisms. Immunol. Today 15: 423-432.
53. Clayton, E., G. Bardi, S. E. Bell, D. Chantry, C. P. Downes, A. Gray, L. A. Humphries, D. Rawlings, H. Reynolds, E. Vigorito, and M. Turner. 2002. A crucial role for the p110 subunit of phosphatidylinositol 3-kinase in B cell development and activation. J. Exp. Med. 196: 753-763.
54. Omori, S. A., and R. C. Rickert. 2007. Phosphatidylinositol 3-kinase (PI3K) signaling and regulation of the antibody response. Cell Cycle 6: 397-402. (Pubitemid 46393440)
55. Jelinek, D. F., T. E. Witzig, and B. K. Arendt. 1997. A role for insulin-like growth factor in the regulation of IL-6-responsive human myeloma cell line growth. J. Immunol. 159: 487-496. (Pubitemid 127493736)
56. Freund, G. G., D. T. Kulas, B. A. Way, and R. A. Mooney. 1994. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines. Cancer Res. 54: 3179-3185. (Pubitemid 24980048)
57. Freund, G. G., D. T. Kulas, and R. A. Mooney. 1993. Insulin and IGF-1 increase mitogenesis and glucose metabolism in the multiple myeloma cell line, RPMI 8226. J. Immunol. 151: 1811-1820.
58. Smith, T. J. 2003. The putative role of fibroblasts in the pathogenesis of Graves' disease: evidence for the involvement of the insulin-like growth factor-1 receptor in fibroblast activation. Autoimmunity 36: 409-415.
59. Smith, T. J., and N. Hoa. 2004. Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the selfantigen, insulin-like growth factor-I receptor. J. Clin. Endocrinol. Metab. 89: 5076-5080.